Answer
Clinical experience with Optison (perflutren) in severe heart failure (NYHA IV) is limited, so it should be used only after careful consideration, with close monitoring during and after administration.
Sources for this answer
- OPTISON 0.19 mg/ml dispersion for injectionGE Healthcare Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked